VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,324,000 | -83.0% | 120,000 | +120.1% | 0.05% | -80.9% |
Q4 2014 | $7,801,000 | +9.1% | 54,509 | 0.0% | 0.27% | +13.3% |
Q3 2014 | $7,152,000 | +427.8% | 54,509 | +407.3% | 0.24% | +336.4% |
Q2 2014 | $1,355,000 | -57.2% | 10,745 | -55.2% | 0.06% | -43.9% |
Q1 2014 | $3,165,000 | +12.3% | 24,010 | 0.0% | 0.10% | +19.5% |
Q4 2013 | $2,819,000 | – | 24,010 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |